Search Tag: Vial

2023 14 Feb

Vial, a global CRO providing next-generation clinical trial management services, announced the addition of Dr. Rajat N Agrawal to Vial’s scientific advisory board (SAB). Dr. Agrawal, an ophthalmologist and retina specialist, will work closely with the company’s leadership team to enhance the scientific strategy of Vial’s Ophthalmology CRO products...Read more

2022 16 Nov

Vial  welcomes Rajesh Pahwa, MBBS, MD, as a new Central Nervous System (CNS) advisory board member to their  Neurology CRO . Dr. Pahwa is Chief of the Parkinson’s and Movement Disorder Division and a professor of neurology at the University of Kansas Medical Center, which has been designated as one of 33 Centers of Excellence in the nation by the...Read more

2022 09 Nov

Vial  welcomes Dr. Joseph Jankovic as a new Central Nervous System (CNS) advisory board member to their  Neurology CRO . Dr. Jankovic is a Professor of Neurology, a Distinguished Chair in Movement Disorders, and the Director of the Parkinson’s Disease Center and Movement Disorders Clinic (PDCMDC) at the Baylor College of Medicine. Dr. Jankovic...Read more

2022 07 Nov

  Vial  welcomes Robert A. Hauser, MD, MBA, as a new Central Nervous System (CNS) advisory board member to their  Neurology CRO . Dr. Hauser is the Director of the Parkinson’s Disease and Movement Disorder Center and a Professor of Neurology, at the University of South Florida. Vial is a tech-enabled  CRO  providing next-generation  clinical trial...Read more

2022 14 Sep

Vial  welcomes Dr. Howard Jack West as a new Oncology  CRO  Advisory Board member. Dr. West is a thoracic oncology specialist and Associate Clinical Professor in Medical Oncology at City of Hope Cancer Center. He also serves as the Clinical Executive Director at AccessHope, a leading-edge cancer care center offering remote consult services. Vial...Read more

2022 11 Sep

Vial  continues to expand its scientific advisory board with new member Dr. Paul Karpecki, who will act as a consultant to Vial’s  Ophthalmology CRO . Dr. Karpecki is the Medical Director of Keplr Vision and Faculty Associate Professor at the University of Pikeville, Kentucky, College of Optometry. Dr. Karpecki has over 20 years of experience...Read more

2022 31 Aug

  Vial  introduces a new member joining their  Oncology CRO  Advisory Board. Eric Jonasch, MD, is a Genitourinary Medical Oncology Professor and Physician at The University of Texas MD Anderson Cancer Center, Houston, TX. Dr. Jonasch will act as a scientific advisor for Vial’s  Oncology CRO  alongside members Dr. Antoni Ribas, Dr. Guru Sonpavde,...Read more

2022 28 Aug

Brian Rini, MD, is the Chief of Clinical Trials at Vanderbilt University and is recognized globally as a leader in genitourinary oncology, kidney cancer, and clinical drug development. Rini will join  Vial’s Oncology CRO  Advisory Board as a scientific advisor. Vial’s mission is to disrupt the clinical trials industry with superior trial management...Read more